Report error Found 49 Enz. Inhib. hit(s) with all data for entry = 11684
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.5nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 8nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 9.34nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 11.2nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 13nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 14.1nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 14.5nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 15.8nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 16nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 18.5nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 27.3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 27.9nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 36.5nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 39nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 57nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 74nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 74.2nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 76nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 85nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 87.7nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 104nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 105nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 151nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 235nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 236nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 300nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 719nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 1.07E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 1.18E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 1.19E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 1.26E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 1.40E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 1.60E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 2.70E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 3.25E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 3.82E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 4.58E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 5.34E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 5.40E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
















































